缩写名/全名 |
BIOMARK MED
Biomarkers in Medicine |
||||||||||||||||||||||||
ISSN号 | 1752-0363 | ||||||||||||||||||||||||
研究方向 | 医学-医学:研究与实验 | ||||||||||||||||||||||||
影响因子 | 2015:2.179, 2016:2.02, 2017:2.346, 2018:2.268, 2019:2.479, | ||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||||||
年文章数 | 127 | ||||||||||||||||||||||||
出版年份 | 2007 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||
录用比例 | 一般 | ||||||||||||||||||||||||
投稿链接 | http://www.futuremedicine.com/page/submitarticle | ||||||||||||||||||||||||
投稿官网 | http://www.futuremedicine.com/loi/bmm | ||||||||||||||||||||||||
h-index | 37 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1752-0363%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | An accurate regression of developmental stages for breast cancer based on transcriptomic biomarkers. Author: Feng X1, Zhang R1, Liu M1, Liu Q1, Li F2, Yan Z2, Zhou F1,2. Journal: Biomark Med. 2019 Jan;13(1):5-15. doi: 10.2217/bmm-2018-0305. Epub 2018 Nov 28. PubMed DOI |
2. | Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis. Author: Mei H1, Liu Y1, Zhou Q1,2, Hu K1,2, Liu Y1. Journal: Biomark Med. 2019 Jan;13(1):45-54. doi: 10.2217/bmm-2018-0128. Epub 2018 Dec 18. PubMed DOI |
3. | Elevated serum CCL4/MIP-1β levels in postmenopausal osteoporosis patients are linked with disease severity. Author: Yang XW1, Wang F2, Qin RZ1, Zhou QL1, Huang HX3. Journal: Biomark Med. 2019 Jan;13(1):17-25. doi: 10.2217/bmm-2018-0250. Epub 2018 Dec 18. PubMed DOI |
4. | 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer. Author: Chen XH1, Zhang WW2, Wang J3, Sun JY2, Li FY2, He ZY2, Wu SG3. Journal: Biomark Med. 2019 Feb;13(2):83-93. doi: 10.2217/bmm-2018-0396. Epub 2018 Dec 19. PubMed DOI |
5. | Wound exudate CXCL6: a potential biomarker for wound healing of diabetic foot ulcers. Author: Wang X1, Li J2, Wang Z3, Deng A2. Journal: Biomark Med. 2019 Feb;13(3):167-174. doi: 10.2217/bmm-2018-0339. Epub 2019 Jan 3. PubMed DOI |
6. | Initial platelet-to-lymphocyte count as prognostic factor in limited-stage small cell lung cancer. Author: Zhang Q1, Qu Y1, Liu H1, Jia H1, Wen F1, Pei S1, Yu H1. Journal: Biomark Med. 2019 Mar;13(4):249-258. doi: 10.2217/bmm-2018-0415. Epub 2019 Jan 9. PubMed DOI |
7. | Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer. Author: Dazhi W1,2, Jing D1, Chunling R3, Mi Z1, Zhixuan X4. Journal: Biomark Med. 2019 Feb;13(2):95-104. doi: 10.2217/bmm-2018-0256. Epub 2019 Feb 15. PubMed DOI |
8. | Pancreatic cancer biomarker detection by two support vector strategies for recursive feature elimination. Author: Wang Y1,2, Liu K1, Ma Q3, Tan Y4, Du W1,2, Lv Y1, Tian Y1,5, Wang H6. Journal: Biomark Med. 2019 Feb;13(2):105-121. doi: 10.2217/bmm-2018-0273. Epub 2019 Feb 15. PubMed DOI |
9. | hsa_circRNA_104597: a novel potential diagnostic and therapeutic biomarker for schizophrenia. Author: Yao G1,2, Niu W3, Zhu X2, He M2, Kong L2, Chen S4, Zhang L2, Cheng Z1. Journal: Biomark Med. 2019 Feb 20. doi: 10.2217/bmm-2018-0447. [Epub ahead of print] PubMed DOI |
10. | Micro-RNA335-5p targeted inhibition of sKlotho and promoted oxidative stress-mediated aging of endothelial cells. Author: Liu Y1,2,3, Lai P4, Deng J5, Hao Q1,2,3, Li X6, Yang M1,2,3, Wang H1,2,3, Dong B1,2,3. Journal: Biomark Med. 2019 Feb 20. doi: 10.2217/bmm-2018-0430. [Epub ahead of print] PubMed DOI |
|
|